BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38351079)

  • 1. Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma.
    Nedal TMV; Moen SH; Roseth IA; Tryggestad SS; Aass KR; Hov GG; Hella H; Sponaas AM; Standal T
    Sci Rep; 2024 Feb; 14(1):3643. PubMed ID: 38351079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.
    Fairfield H; Dudakovic A; Khatib CM; Farrell M; Costa S; Falank C; Hinge M; Murphy CS; DeMambro V; Pettitt JA; Lary CW; Driscoll HE; McDonald MM; Kassem M; Rosen C; Andersen TL; van Wijnen AJ; Jafari A; Reagan MR
    Cancer Res; 2021 Feb; 81(3):634-647. PubMed ID: 33218968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression.
    Wang J; Peng Z; Guo J; Wang Y; Wang S; Jiang H; Wang M; Xie Y; Li X; Hu M; Xie Y; Cheng H; Li T; Jia L; Song J; Wang Y; Hou J; Liu Z
    Cancer Immunol Res; 2023 Oct; 11(10):1384-1399. PubMed ID: 37586075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.
    Bordini J; Bertilaccio MT; Ponzoni M; Fermo I; Chesi M; Bergsagel PL; Camaschella C; Campanella A
    Haematologica; 2015 Jun; 100(6):834-841. PubMed ID: 25715406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice.
    Wang L; Deng Q; Hu H; Liu M; Gong Z; Zhang S; Xu-Monette ZY; Lu Z; Young KH; Ma X; Li Y
    J Hematol Oncol; 2019 Jul; 12(1):70. PubMed ID: 31277689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.
    Morris EV; Edwards CM
    J Cell Physiol; 2018 Dec; 233(12):9159-9166. PubMed ID: 29943829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
    Zhu D; Wang Z; Zhao JJ; Calimeri T; Meng J; Hideshima T; Fulciniti M; Kang Y; Ficarro SB; Tai YT; Hunter Z; McMilin D; Tong H; Mitsiades CS; Wu CJ; Treon SP; Dorfman DM; Pinkus G; Munshi NC; Tassone P; Marto JA; Anderson KC; Carrasco RD
    Nat Med; 2015 Jun; 21(6):572-80. PubMed ID: 26005854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients.
    Gadó K; Nagy G; Hasitz A; Tóth BE; Rimanóczi E; Domján G
    Neuroimmunomodulation; 2001; 9(2):95-102. PubMed ID: 11549891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma.
    Bradey AL; Fitter S; Duggan J; Wilczek V; Williams CMD; Cheney EA; Noll JE; Tangseefa P; Panagopoulos V; Zannettino ACW
    Sci Rep; 2022 Jul; 12(1):13128. PubMed ID: 35908046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
    Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
    Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome.
    Santiago V; Lazaryan A; McClune B; McKenna RW; Courville EL
    Leuk Lymphoma; 2018 Apr; 59(4):958-966. PubMed ID: 28728454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and myeloma: Clinical and mechanistic contributions to disease progression.
    Marques-Mourlet C; Di Iorio R; Fairfield H; Reagan MR
    Front Endocrinol (Lausanne); 2023; 14():1118691. PubMed ID: 36909335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
    Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
    Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adhesion molecules in multiple myeloma.
    Cook G; Dumbar M; Franklin IM
    Acta Haematol; 1997; 97(1-2):81-9. PubMed ID: 8980613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
    Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
    Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess bone marrow B-cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival.
    Byrne E; Naresh KN; Giles C; Rahemtulla A
    Br J Haematol; 2011 Nov; 155(4):509-11. PubMed ID: 21539533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of circulating and bone marrow myeloma cells in patients with multiple myeloma and its clinical significance].
    Jiang YQ; Li JY; Wu YJ; Yang H; Shen YF; Chen LJ; Xu W; Qian SX; Wu HX; Lu H; Shen RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):908-12. PubMed ID: 17096887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.